Molecular Imaging Corporation ("MLRI" or the "Company") (OTCBB:MLRI), a leading provider of Molecular Imaging services to healthcare entities in the U.S., today announced that it has sent a letter to the Berlin Stock Exchange requesting immediate de-listing from that exchange. The Company's common stock is currently listed on the Berlin Stock Exchange without the Company's consent.
